IhtshamUlHaqMD(He/Him)

Neurology • Miami, FL

Movement Disorder, Neurodegenerative

Professor and Division Chief, Movement Disorders, Miami University Miller School of Medicine

Join to view full profile

Dr. Haq is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Haq's full profile

Already have an account?

Office
1120 NW 14th St
Ste 1363
Miami, FL 33136
Phone+1 305-243-5823

Fax+1 305-243-4713

Education & Training

University of FloridaFellowship, Neuromuscular Medicine (Neurology), 2006 - 2009
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalInternship, Internal Medicine, 2002 - 2003
State University of New York Downstate Medical Center College of MedicineClass of 2002

Certifications & Licensure

FL State Medical License 2020 - 2026
NC State Medical License 2009 - 2022
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2013

Clinical Trials

Effectiveness of Deep Brain Stimulation for Treating People With Treatment Resistant Obsessive-Compulsive Disorder Start of enrollment: 2008 Mar 01
Active, not recruiting
Phase 4
Studies of the Variable Phenotypic Presentations of Rapid-Onset Dystonia Parkinsonism and Other Movement Disorders Start of enrollment: 2008 Apr 01
Recruiting
The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias Start of enrollment: 2011 Jan 01
Completed
Mobile Decision Support System for Nurse Management of Neuromodulation Therapy Start of enrollment: 2015 Jul 01
Completed
Not Applicable
Automated Deep Brain Stimulation Programming Using Functional Mapping Start of enrollment: 2018 Oct 01
Recruiting
Not Applicable
Trial of Parkinson's And Zoledronic Acid Start of enrollment: 2019 Nov 15
Recruiting
Phase 4
A Study to Assess the Safety of BIIB122 Tablets and if it Can Slow the Worsening of Early-Stage Parkinson's Disease in Participants Between the Ages of 30 and 80 Start of enrollment: 2022 Apr 19
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

69 citations
Low-frequency versus high-frequency subthalamic nucleus deep brain stimulation on postural control and gait in Parkinson's disease: a quantitative study.
Srikant Vallabhajosula, Ihtsham Haq, Nelson Hwynn, Genko Oyama, Michael S. Okun
Brain Stimulation. 2015-01-01
12 citations
Analysis of the prevalence and onset of dysphonia and dysphagia symptoms in movement disorders at an academic medical center.
Mary E. Finger, Lyndsay L. Madden, Ihtsham Haq, Christopher J. McLouth, Mustafa S. Siddiqui
Journal of Clinical Neuroscience. 2019-06-01
76 citations
Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blin...
Jerrold L. Vitek, Roshini Jain, Lilly Chen, Alexander I. Tröster, Lauren E. Schrock
The Lancet. Neurology. 2020-06-01

Journal Articles

Subthalamic nucleus deep brain stimulation with a multiple
Jerrold L Vitek, Roshini Jain, Lilly Chen, Alexander I Tröster, Lauren E Schrock, Paul A House, Monique L Giroux, Adam O Hebb, Sierra M Farris, Lancet Neurology

Press Mentions

Neurosurgeons Treating Tourette’s Syndrome and OCD with Deep Brain StimulationFebruary 4th, 2021
Wake Forest Baptist Doctors Talk About Parkinson’s DiseaseNovember 17th, 2017
Mother to Raise Awareness About Neurological ConditionJanuary 23rd, 2016
Join now to see all

Professional Memberships

American Academy of Neurology - AAN
Member
International Movement Disorders Society
Member

Other Languages

Urdu